13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 46 holding rows worth $434,880,000.
- Accession
- 0001140361-14-021247
- Filer
- CIK 1583977
- Filed
- 2014-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 46 entries on the cover page, a total value of $434,880,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $434,881,000 with VALUE read as thousands by filing date, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MEDIVATION INC | 58501N101 | COM | 600,000 | $38,622,000 | thousands by filing date | |
| CUBIST PHARMACEUTICALS INC | 229678107 | COM | 300,000 | $21,945,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 207,500 | $21,609,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 300,000 | $20,463,000 | thousands by filing date | |
| RECEPTOS, INC. | 756207106 | COMMON STOCK | 450,000 | $18,873,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 2,000,000 | $17,960,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 50,000 | $16,490,000 | thousands by filing date | |
| ARROWHEAD RESEARCH CORP | 042797209 | COM | 1,000,000 | $16,420,000 | thousands by filing date | |
| IDENIX PHARMACEUTICALS INC | 45166R204 | COM | 2,500,000 | $15,075,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 550,000 | $14,377,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 100,000 | $13,868,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 350,000 | $13,409,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 300,000 | $12,408,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,168,000 | $12,357,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 200,000 | $11,354,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 600,000 | $10,848,000 | thousands by filing date | |
| ACELRX PHARMACEUTICALS INC | 00444T100 | COM | 750,000 | $9,008,000 | thousands by filing date | |
| SORRENTO THERAPEUTICS INC | 83587F202 | COMMON STOCK | 700,000 | $8,974,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 300,000 | $8,844,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 200,000 | $8,818,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 280,000 | $8,649,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 120,000 | $8,312,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 400,000 | $8,260,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 1,750,000 | $8,225,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 469,400 | $7,665,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 300,000 | $7,299,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 300,000 | $6,852,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 500,000 | $6,035,000 | thousands by filing date | |
| GALECTIN THERAPEUTICS INC | 363225202 | COMMON STOCK | 348,000 | $5,328,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 200,000 | $5,180,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 400,000 | $5,100,000 | thousands by filing date | |
| ROCKWELL MED INC | 774374102 | COM | 400,000 | $5,064,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 1,000,000 | $4,530,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 500,000 | $3,660,000 | thousands by filing date | |
| GENVEC INC NEW | 37246C307 | cs | 1,329,300 | $3,523,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 50,000 | $3,500,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 50,000 | $3,357,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 1,000,000 | $3,170,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 246,877 | $3,143,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,500,000 | $3,135,000 | thousands by filing date | |
| AUSPEX PHARMACE | 05211J102 | Common Stock | 100,000 | $3,076,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 10,000 | $3,059,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 60,000 | $2,933,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 200,000 | $1,804,000 | thousands by filing date | |
| IDERA PHARMACEUTICALS INC | 45168K306 | COM | 400,000 | $1,632,000 | thousands by filing date | |
| CELSUS THERAPEUTICS PLC | 15119A202 | COM | 103,000 | $668,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-14-021247 | this filing | 2014-05-15 | acceptance time not in the bulk data set |